Complete Filing Data
Dianthus Therapeutics, Inc. /DE/ reported Stockholders Equity of $493.40 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Dianthus Therapeutics, Inc. /DE/ did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$162.3M | -$85.0M | -$43.6M | -$28.5M | -$71.1M | -$74.9M | -$76.8M | -$57.5M | -$35.5M | -$9.4M |
| Revenue * | $2.0M | $6.2M | $2.8M | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Operating Income Loss | -$177.9M | -$101.9M | -$48.2M | -$29.7M | -$74.7M | -$78.7M | -$83.0M | -$60.0M | -$35.7M | -$9.3M |
| Research And Development Expense | $145.6M | $83.1M | $32.8M | $29.4M | $46.8M | $50.6M | $59.2M | $41.3M | $27.9M | $5.8M |
| Operating Expenses | $180.0M | $108.1M | $51.0M | $36.1M | $74.7M | $78.7M | $83.0M | $60.0M | $35.7M | $9.3M |
| General And Administrative Expense | $34.3M | $25.0M | $18.2M | $6.7M | $27.9M | $28.1M | $23.8M | $18.6M | $7.8M | $3.5M |
| Comprehensive Income Net Of Tax | -$162.0M | -$84.9M | -$43.3M | -$28.6M | -$71.1M | -$75.0M | -$76.8M | -$57.5M | -$35.5M | -$9.4M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $383.0K | $59.0K | $208.0K | -$161.0K | -$7.0K | -$31.0K | $16.0K | -$8.0K | ||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $383.0K | $59.0K | $208.0K | -$161.0K | -$7.0K | -$31.0K | $16.0K | -$8.0K | ||
| Net Income Loss Available To Common Stockholders Basic | -$76.8M | -$57.6M | -$35.5M | -$9.7M | ||||||
| Nonoperating Income Expense | $15.6M | $16.9M | $4.6M | $1.2M | $2.4M | $236.0K | -$163.0K | |||
| Other Nonoperating Income Expense | -$974.0K | -$554.0K | -$60.0K | -$52.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$36.8M | -$31.6M | -$29.5M | -$25.2M | -$17.6M | -$13.7M | -$14.8M | -$11.1M | -$7.1M | -$7.8M | -$5.7M | -$4.9M | -$17.4M | -$16.9M | -$17.5M | -$17.7M | -$19.1M | -$20.0M | -$23.2M | -$21.0M | -$17.7M | -$14.8M | -$16.7M | -$16.0M | -$13.7M | -$11.2M | -$8.0M | -$6.9M | -$15.7M | -$4.8M |
| Revenue * | $396.0K | $193.0K | $1.2M | $2.2M | $1.9M | $874.0K | $924.0K | $1.2M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Operating Income Loss | -$40.3M | -$34.9M | -$33.2M | -$29.9M | -$22.2M | -$17.8M | -$15.8M | -$11.8M | -$7.7M | -$8.3M | -$18.1M | -$23.8M | -$18.2M | -$17.6M | -$18.7M | -$18.4M | -$20.0M | -$21.2M | -$24.6M | -$22.6M | -$19.3M | -$16.4M | -$17.9M | -$16.7M | -$14.0M | -$11.3M | -$8.2M | -$7.0M | -$15.7M | -$4.8M |
| Research And Development Expense | $32.5M | $26.3M | $27.0M | $25.5M | $18.1M | $13.1M | $8.0M | $10.3M | $5.8M | $7.2M | $11.6M | $16.5M | $10.8M | $11.1M | $11.7M | $11.8M | $12.6M | $14.0M | $16.5M | $13.4M | $10.5M | $11.4M | $9.7M | $7.8M | $5.2M | $13.8M | ||||
| Operating Expenses | $40.7M | $35.1M | $34.3M | $32.1M | $24.1M | $18.7M | $16.7M | $12.7M | $8.2M | $9.4M | $18.1M | $23.8M | $18.2M | $17.6M | $18.7M | $18.4M | $20.0M | $21.2M | $22.6M | $19.3M | $16.4M | $16.7M | $14.0M | $11.3M | $7.0M | $15.7M | ||||
| General And Administrative Expense | $8.2M | $8.9M | $7.3M | $6.5M | $6.0M | $5.6M | $8.7M | $2.5M | $2.3M | $2.2M | $6.5M | $7.3M | $7.5M | $6.5M | $7.0M | $6.6M | $7.4M | $7.3M | $6.1M | $5.9M | $5.8M | $5.3M | $4.3M | $3.5M | $1.8M | $1.9M | ||||
| Comprehensive Income Net Of Tax | -$36.7M | -$31.8M | -$29.3M | -$24.5M | -$17.6M | -$13.8M | -$14.7M | -$11.1M | -$7.0M | -$7.9M | -$17.4M | -$23.4M | -$17.4M | -$16.9M | -$17.5M | -$17.8M | -$19.3M | -$19.7M | -$21.0M | -$17.6M | -$14.8M | -$16.0M | -$13.7M | -$11.2M | -$6.9M | -$15.7M | ||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $65.0K | -$172.0K | $164.0K | $718.0K | -$10.0K | -$74.0K | $15.0K | $38.0K | $104.0K | -$150.0K | -$133.0K | -$439.0K | -$1.0K | -$7.0K | $32.0K | -$114.0K | -$210.0K | $355.0K | -$56.0K | $98.0K | $49.0K | |||||||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $65.0K | -$172.0K | $164.0K | $718.0K | -$10.0K | -$74.0K | $15.0K | $38.0K | $104.0K | -$150.0K | -$133.0K | -$439.0K | -$1.0K | -$7.0K | $32.0K | -$114.0K | -$210.0K | $355.0K | -$56.0K | $98.0K | $49.0K | |||||||||
| Net Income Loss Available To Common Stockholders Basic | -$23.2M | -$21.0M | -$17.7M | -$14.8M | -$16.7M | -$16.0M | -$13.7M | -$11.2M | -$8.0M | -$6.9M | -$15.4M | -$5.2M | ||||||||||||||||||
| Nonoperating Income Expense | $3.5M | $3.3M | $3.7M | $4.7M | $4.6M | $4.1M | $996.0K | $636.0K | $594.0K | $470.0K | ||||||||||||||||||||
| Other Nonoperating Income Expense | -$360.0K | -$107.0K | -$98.0K | $22.0K | -$80.0K | -$114.0K | -$15.0K | -$23.0K | -$3.0K | -$2.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $493.4M | $352.5M | $168.9M | -$44.4M | -$17.2M | $143.9M | $141.2M | $145.6M | -$42.1M | -$8.9M | -$289.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $51.3M | $23.0M | $132.4M | $15.4M | $7.6M | $59.9M | $66.9M | $60.1M | $51.6M | $4.5M | $500.0K |
| Cash And Cash Equivalents At Carrying Value | $51.1M | $22.8M | $132.3M | $15.4M | $131.7M | $58.2M | $65.1M | $58.3M | $51.4M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $28.2M | -$109.4M | $117.0M | $7.8M | $73.5M | -$6.9M | $6.7M | $8.6M | $47.0M | $4.0M | |
| Retained Earnings Accumulated Deficit | -$336.7M | -$174.4M | -$89.4M | -$45.9M | -$325.6M | -$254.4M | -$179.5M | -$102.7M | -$45.2M | ||
| Property Plant And Equipment Net | $296.0K | $194.0K | $185.0K | $142.0K | $7.5M | $8.3M | $9.9M | $10.2M | $2.0M | ||
| Prepaid Expense And Other Assets Current | $5.1M | $4.9M | $3.3M | $905.0K | $3.8M | $2.7M | $4.1M | $2.8M | $936.0K | ||
| Liabilities Current | $30.7M | $18.5M | $9.6M | $8.2M | $10.9M | $11.4M | $14.1M | $10.4M | $4.1M | ||
| Liabilities And Stockholders Equity | $530.9M | $374.0M | $179.4M | $83.1M | $189.9M | $161.6M | $161.5M | $157.3M | $54.5M | ||
| Liabilities | $37.5M | $21.5M | $10.5M | $9.5M | $17.3M | $17.7M | $20.3M | $11.7M | $4.1M | ||
| Common Stock Value | $43.0K | $31.0K | $15.0K | $0.00 | $59.0K | $49.0K | $39.0K | $33.0K | $2.0K | ||
| Assets Current | $409.4M | $280.9M | $177.5M | $82.0M | $180.7M | $151.5M | $149.8M | $145.3M | $52.5M | ||
| Assets | $530.9M | $374.0M | $179.4M | $83.1M | $189.9M | $161.6M | $161.5M | $157.3M | $54.5M | ||
| Additional Paid In Capital Common Stock | $829.6M | $526.7M | $258.2M | $1.7M | $498.2M | $398.3M | $320.6M | $248.3M | $3.1M | ||
| Accounts Payable Current | $9.7M | $4.6M | $2.6M | $1.2M | $3.0M | $3.8M | $2.8M | $3.5M | $167.0K | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $489.0K | $106.0K | $47.0K | -$161.0K | -$30.0K | -$23.0K | $8.0K | -$8.0K | |||
| Accrued Liabilities And Other Liabilities | $7.8M | $7.7M | $11.3M | $6.9M | $4.0M | ||||||
| Restricted Cash Noncurrent | $1.8M | $1.8M | $1.8M | $1.8M | |||||||
| Operating Lease Right Of Use Asset | $1.3M | $1.6M | $615.0K | $814.0K | $0.00 | ||||||
| Operating Lease Liability Noncurrent | $1.0M | $1.2M | $168.0K | $438.0K | $0.00 | ||||||
| Operating Lease Liability Current | $367.0K | $320.0K | $417.0K | $350.0K | $0.00 | ||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$95.0K | -$1.0K | -$67.0K | |||||||
| Deferred Rent Credit Noncurrent | $0.00 | $6.4M | $6.3M | $6.2M | $1.2M | ||||||
| Marketable Securities Current | $54.4M | $45.3M | $90.7M | $80.7M | $84.2M | ||||||
| Accretion Amortization Of Discounts And Premiums Investments | $6.2M | $6.0M | $1.4M | $606.0K | |||||||
| Restricted Cash | $167.0K | $230.0K | $66.0K | $60.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q4 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $546.5M | $303.1M | $328.6M | $337.9M | $358.2M | $372.7M | $178.4M | -$61.5M | -$50.8M | -$34.8M | -$27.5M | -$22.1M | $189.7M | $202.9M | $129.1M | $158.6M | $173.9M | $125.4M | $161.5M | $179.6M | $134.0M | $159.8M | $172.2M | -$51.9M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $56.2M | $13.5M | $10.3M | $33.9M | $314.2M | $329.8M | $157.3M | $40.4M | $23.3M | $36.9M | $56.6M | $73.5M | $159.3M | $156.8M | $51.1M | $143.5M | $138.1M | $76.7M | $87.3M | $34.9M | $33.0M | $161.6M | $175.4M | $41.5M | ||||
| Cash And Cash Equivalents At Carrying Value | $56.0M | $13.2M | $10.1M | $33.7M | $314.2M | $329.7M | $157.3M | $40.3M | $23.2M | $36.9M | $54.8M | $71.8M | $157.5M | $155.0M | $49.3M | $141.7M | $136.3M | $74.9M | $85.5M | $33.1M | $31.2M | $159.7M | $173.4M | $60.0M | $63.8M | $4.5M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$12.7M | $197.4M | $7.8M | -$59.9M | -$8.9M | $9.9M | -$27.1M | -$9.9M | ||||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$272.3M | -$235.5M | -$203.9M | -$146.0M | -$120.8M | -$103.2M | -$78.9M | -$434.5M | -$431.2M | -$78.9M | -$365.8M | -$348.5M | -$306.3M | -$288.8M | -$271.9M | -$236.3M | -$218.6M | -$199.5M | -$156.3M | -$135.3M | -$117.6M | -$86.0M | -$70.0M | |||||
| Property Plant And Equipment Net | $185.0K | $207.0K | $191.0K | $189.0K | $189.0K | $195.0K | $195.0K | $0.00 | $0.00 | $6.3M | $6.6M | $7.0M | $8.0M | $8.4M | $7.7M | $8.6M | $9.1M | $9.5M | $10.2M | $10.6M | $10.6M | $8.1M | $2.9M | |||||
| Prepaid Expense And Other Assets Current | $6.2M | $6.2M | $6.8M | $3.7M | $3.3M | $3.0M | $832.0K | $1.0M | $2.9M | $3.8M | $2.6M | $3.6M | $3.9M | $2.4M | $2.8M | $2.5M | $3.4M | $2.7M | $4.7M | $10.7M | $7.8M | $3.0M | $2.3M | |||||
| Liabilities Current | $23.9M | $20.1M | $17.0M | $15.7M | $10.0M | $9.0M | $13.1M | $4.0M | $6.0M | $12.9M | $11.3M | $14.1M | $10.1M | $11.1M | $9.2M | $9.9M | $10.4M | $12.7M | $9.6M | $9.9M | $7.9M | $11.9M | $7.6M | |||||
| Liabilities And Stockholders Equity | $577.4M | $326.1M | $348.6M | $354.2M | $369.0M | $382.5M | $192.5M | $78.6M | $83.4M | $164.1M | $175.1M | $194.4M | $206.2M | $220.4M | $144.6M | $174.6M | $190.7M | $144.4M | $177.2M | $195.4M | $147.7M | $172.8M | $180.6M | |||||
| Liabilities | $31.0M | $23.0M | $20.0M | $16.4M | $10.7M | $9.8M | $14.1M | $4.0M | $6.0M | $40.1M | $39.4M | $43.2M | $16.5M | $17.5M | $15.6M | $16.1M | $16.8M | $19.0M | $15.7M | $15.9M | $13.7M | $13.0M | $8.4M | |||||
| Common Stock Value | $43.0K | $32.0K | $32.0K | $29.0K | $29.0K | $29.0K | $15.0K | $61.0K | $61.0K | $61.0K | $59.0K | $59.0K | $59.0K | $59.0K | $49.0K | $48.0K | $48.0K | $39.0K | $39.0K | $39.0K | $34.0K | $33.0K | $33.0K | |||||
| Assets Current | $413.8M | $263.6M | $271.0M | $287.5M | $365.7M | $380.9M | $191.5M | $78.6M | $83.4M | $132.1M | $142.0M | $160.2M | $196.5M | $210.2M | $135.1M | $164.3M | $179.9M | $133.1M | $165.2M | $183.0M | $135.1M | $162.9M | $175.9M | |||||
| Assets | $577.4M | $326.1M | $348.6M | $354.2M | $369.0M | $382.5M | $192.5M | $78.6M | $83.4M | $164.1M | $175.1M | $194.4M | $206.2M | $220.4M | $144.6M | $174.6M | $190.7M | $144.4M | $177.2M | $195.4M | $147.7M | $172.8M | $180.6M | |||||
| Additional Paid In Capital Common Stock | $818.5M | $538.5M | $532.2M | $483.1M | $479.0M | $475.9M | $257.2M | $509.0M | $508.6M | $506.3M | $502.0M | $500.1M | $495.9M | $491.7M | $400.9M | $394.7M | $392.3M | $324.5M | $317.7M | $314.6M | $251.5M | $245.8M | $242.2M | |||||
| Accounts Payable Current | $6.7M | $5.4M | $8.3M | $7.6M | $3.7M | $2.6M | $1.4M | $813.0K | $1.1M | $2.6M | $2.0M | $4.4M | $1.9M | $2.9M | $2.1M | $2.4M | $2.7M | $3.9M | $2.0M | $2.3M | $3.0M | $4.9M | $1.5M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $163.0K | $98.0K | $270.0K | $681.0K | -$37.0K | -$27.0K | -$4.0K | -$3.0K | -$16.0K | -$462.0K | -$602.0K | -$469.0K | $1.0K | $2.0K | $9.0K | $39.0K | $153.0K | $363.0K | $83.0K | $139.0K | $41.0K | |||||||
| Accrued Liabilities And Other Liabilities | $3.2M | $4.9M | $8.3M | $6.7M | $5.8M | $6.4M | $8.3M | $8.2M | $7.1M | $7.5M | $7.7M | $8.8M | $7.6M | $7.6M | $4.9M | $7.0M | $6.1M | |||||||||||
| Restricted Cash Noncurrent | $0.00 | $0.00 | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | |||||||||||
| Operating Lease Right Of Use Asset | $1.3M | $1.4M | $1.4M | $352.0K | $442.0K | $530.0K | $698.0K | $0.00 | $0.00 | $23.9M | $24.7M | $25.4M | ||||||||||||||||
| Operating Lease Liability Noncurrent | $1.1M | $1.1M | $1.2M | $0.00 | $30.0K | $97.0K | $257.0K | $0.00 | $0.00 | $27.2M | $28.2M | $29.1M | ||||||||||||||||
| Operating Lease Liability Current | $217.0K | $211.0K | $226.0K | $311.0K | $377.0K | $400.0K | $413.0K | $0.00 | $0.00 | $3.6M | $3.4M | $3.2M | ||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||
| Gain Loss On Sale Of Property Plant Equipment | -$3.4M | $0.00 | -$90.0K | |||||||||||||||||||||||||
| Deferred Rent Credit Noncurrent | $0.00 | $0.00 | $0.00 | $6.4M | $6.4M | $6.4M | $6.2M | $6.4M | $6.3M | $6.1M | $5.9M | $5.8M | ||||||||||||||||
| Marketable Securities Current | $69.3M | $84.6M | $84.8M | $35.1M | $52.8M | $83.0M | $20.1M | $40.2M | $55.5M | $75.1M | $139.2M | $96.1M | ||||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $2.3M | $1.1M | $1.9M | $2.3M | $422.0K | $518.0K | $358.0K | |||||||||||||||||||||
| Restricted Cash | $167.0K | $231.0K | $231.0K | $229.0K | $66.0K | $66.0K | $65.0K | $125.0K | $60.0K | $60.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $22.8M | $12.9M | $2.9M | $1.5M | $10.3M | $9.9M | $10.0M | $10.7M | $2.3M | $662.0K |
| Net Cash Provided By Used In Operating Activities | -$129.1M | -$78.2M | -$36.9M | -$29.1M | -$59.5M | -$64.0M | -$57.1M | -$41.9M | -$22.3M | -$6.5M |
| Net Cash Provided By Used In Investing Activities | -$122.8M | -$286.8M | $20.3M | -$59.8M | $43.4M | -$10.6M | $1.5M | -$91.7M | -$2.2M | -$139.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $235.0K | $1.6M | -$123.0K | $631.0K | $1.1M | -$1.4M | $1.4M | $1.8M | $895.0K | $41.0K |
| Net Cash Provided By Used In Financing Activities | $280.1M | $255.6M | $133.6M | $96.7M | $89.6M | $67.7M | $62.3M | $142.1M | $71.5M | $10.7M |
| Proceeds From Stock Options Exercised | $7.9M | $1.1M | $5.0K | $0.00 | $3.4M | $3.1M | $2.0M | $29.0K | ||
| Payments To Acquire Property Plant And Equipment | $314.0K | $1.3M | $400.0K | $3.1M | $7.7M | $2.2M | $139.0K | |||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $973.0K | $153.0K | -$3.6M | $5.1M | $2.2M | $3.3M | $631.0K | |||
| Increase Decrease In Accounts Payable | -$801.0K | -$720.0K | $948.0K | $145.0K | $2.5M | -$1.1M | $1.0M | |||
| Depreciation Depletion And Amortization | $1.9M | $2.0M | $2.0M | $1.8M | $875.0K | $376.0K | $6.0K | |||
| Payments Of Stock Issuance Costs | $0.00 | $14.7M | $0.00 | $0.00 | $303.0K | $297.0K | $598.0K | $3.1M | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $60.0M | $90.0M | $85.5M | $149.0M | ||||||
| Proceeds From Issuance Of Common Stock | $317.0K | $0.00 | $0.00 | $2.9M | $0.00 | $64.9M | $60.9M | $93.0M | ||
| Payments To Acquire Marketable Securities | $69.5M | $45.3M | $95.7M | $144.4M | $84.0M | |||||
| Increase Decrease In Prepaid Rent | $0.00 | -$116.0K | -$77.0K | -$5.0M | -$1.2M | |||||
| Payments For Capital Improvements | $213.0K | $105.0K | $110.0K | $139.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $5.3M | $2.0M | $533.0K | $1.9M | $2.2M | $2.7M | $2.6M | $1.4M |
| Net Cash Provided By Used In Operating Activities | -$27.6M | -$14.9M | -$10.3M | -$19.7M | -$16.8M | -$16.7M | -$14.9M | -$9.6M |
| Net Cash Provided By Used In Investing Activities | $14.8M | -$5.5M | $18.1M | -$40.1M | $7.5M | $25.4M | -$12.7M | -$161.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.9M | -$241.0K | -$116.0K | -$132.0K | $105.0K | -$1.4M | $5.0M | $60.0K |
| Net Cash Provided By Used In Financing Activities | $161.0K | $217.8M | $0.00 | $0.00 | $418.0K | $1.1M | $563.0K | -$175.0K |
| Proceeds From Stock Options Exercised | $31.0K | $271.0K | $0.00 | $418.0K | $1.1M | $563.0K | ||
| Payments To Acquire Property Plant And Equipment | $245.0K | $27.0K | $7.0K | $131.0K | $1.3M | $161.0K | ||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$3.3M | -$859.0K | -$578.0K | -$2.5M | -$1.6M | -$1.2M | ||
| Increase Decrease In Accounts Payable | -$1.2M | $1.4M | -$1.6M | $1.1M | -$658.0K | $1.2M | ||
| Depreciation Depletion And Amortization | $421.0K | $511.0K | $474.0K | $493.0K | $423.0K | $147.0K | ||
| Payments Of Stock Issuance Costs | $0.00 | $12.4M | $0.00 | $166.0K | ||||
| Proceeds From Sale And Maturity Of Marketable Securities | $35.0M | $0.00 | $7.5M | $30.5M | $7.5M | |||
| Proceeds From Issuance Of Common Stock | $129.0K | $0.00 | ||||||
| Payments To Acquire Marketable Securities | $9.8M | $40.1M | $5.0M | $19.0M | ||||
| Increase Decrease In Prepaid Rent | -$72.0K | -$131.0K | -$4.5M | |||||
| Payments For Capital Improvements | $24.0K | $32.0K | $14.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$4.20 | -$2.55 | -$8.45 | -$32.57 | -$1.29 | -$1.71 | -$2.07 | -$3.13 | -$19.12 | -$65.15 |
| Common Stock Shares Issued | 43.2M | 31.1M | 14.8M | 875.3K | 58.8M | 48.5M | 39.5M | 34.3M | 4.5M | |
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 8.7M | 150.0M | 150.0M | 150.0M | 150.0M | 70.0M | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 0.00 | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 38.6M | 33.3M | 5.2M | 874.2K | 54.9M | 43.9M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 38.6M | 33.3M | 5.2M | 874.2K | 54.9M | 43.9M | ||||
| Earnings Per Share Basic | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 | $-1.71 | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 43.9M | 37.0M | 18.4M | 1.9M | 149.4K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.97 | -$0.88 | -$0.82 | -$0.74 | -$0.51 | -$0.54 | -$3.78 | -$12.73 | -$8.10 | -$8.90 | -$0.29 | -$0.39 | -$0.30 | -$0.32 | -$0.36 | -$0.37 | -$0.48 | -$0.51 | -$0.59 | -$0.54 | -$0.48 | -$0.44 | -$0.50 | -$0.49 | -$3.13 | -$4.53 | -$3.59 | -$3.44 | -$8.90 | -$3.59 |
| Common Stock Shares Issued | 42.9M | 32.2M | 32.1M | 29.4M | 29.4M | 29.3M | 14.8M | 60.7M | 60.6M | 60.6M | 58.8M | 58.8M | 58.8M | 58.5M | 48.6M | 48.3M | 48.3M | 39.6M | 39.4M | 39.3M | 34.4M | 34.3M | 34.4M | |||||||
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | |||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Weighted Average Number Of Shares Outstanding Basic | 37.8M | 35.8M | 35.8M | 34.2M | 34.2M | 25.7M | 3.9M | 874.9K | 874.7K | 874.3K | 58.8M | 58.8M | 58.6M | 53.7M | 48.6M | |||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 37.8M | 35.8M | 35.8M | 34.2M | 34.2M | 25.7M | 3.9M | 874.9K | 874.7K | 874.3K | 58.8M | 58.8M | 58.6M | 53.7M | 48.6M | |||||||||||||||
| Earnings Per Share Basic | $-0.97 | $-0.88 | $-0.82 | $-0.74 | $-0.51 | $-0.54 | $-3.78 | $-12.73 | $-8.10 | $-8.90 | $-0.29 | $-0.39 | $-0.30 | $-0.32 | $-0.36 | |||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 58.6M | 53.7M | 48.6M | 48.3M | 39.6M | 39.4M | 38.8M | 36.7M | 33.4M | 33.0M | 4.4M | 2.5M | 2.0M | 1.7M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $22.8M | $12.9M | $2.9M | $1.5M | $10.3M | $9.9M | $10.0M | $10.7M | $2.3M | $662.0K |
| Interest And Other Income | $4.4M | $3.6M | $3.8M | $6.2M | $2.4M | $236.0K | ||||
| Stock Issued During Period Value Stock Options Exercised | $7.9M | $1.1M | $5.0K | $115.0K | $3.4M | $3.1M | $2.0M | $29.0K | ||
| Investment Income Net Amortization Of Discount And Premium | -$208.0K | -$708.0K | -$179.0K | $1.0M | $190.0K | |||||
| Stock Issued During Period Value New Issues | $39.2M | $71.8M | $2.8M | $86.1M | $64.6M | $60.3M | $89.9M | |||
| Foreign Currency Transaction Gain Loss Before Tax | -$57.0K | -$64.0K | -$85.0K | $136.0K | ||||||
| Depreciation | $111.0K | $96.0K | $67.0K | $30.0K | ||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $317.0K | $141.0K | $104.0K | |||||||
| Capital Expenditures Incurred But Not Yet Paid | $245.0K | $0.00 | $1.5M | $375.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.8M | $5.7M | $5.3M | $3.8M | $3.1M | $2.0M | $1.2M | $462.0K | $533.0K | $661.0K | $279.0K | $65.0K | $3.8M | $2.1M | $2.2M | $2.4M | $2.5M | $2.7M | $2.8M | $2.6M | $2.6M | $3.7M | $3.1M | $1.4M | |
| Interest And Other Income | $4.1M | $3.0M | $1.2M | $812.0K | $884.0K | $818.0K | $682.0K | $1.2M | $703.0K | $933.0K | $1.2M | $1.7M | $1.6M | $1.5M | $687.0K | $365.0K | $145.0K | $102.0K | |||||||
| Stock Issued During Period Value Stock Options Exercised | $2.2M | $568.0K | $31.0K | $296.0K | $47.0K | $271.0K | $5.0K | $425.0K | $2.5M | $418.0K | $78.0K | $693.0K | $1.1M | $257.0K | $287.0K | $563.0K | $29.0K | ||||||||
| Investment Income Net Amortization Of Discount And Premium | $336.0K | -$115.0K | -$216.0K | -$14.0K | $312.0K | ||||||||||||||||||||
| Stock Issued During Period Value New Issues | $71.6M | $2.8M | $64.6M | $60.3M | $90.0M | ||||||||||||||||||||
| Foreign Currency Transaction Gain Loss Before Tax | -$2.0K | -$30.0K | -$22.0K | -$48.0K | -$31.0K | -$12.0K | -$16.0K | -$28.0K | -$9.0K | $56.0K | |||||||||||||||
| Depreciation | $27.0K | $30.0K | $27.0K | $25.0K | $23.0K | $22.0K | $19.0K | $15.0K | $14.0K | $6.0K | |||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $188.0K | $129.0K | $49.0K | $86.0K | $42.0K | ||||||||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $1.1M | $85.0K |
Most recent annual filing with the SEC: March 9, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.